DOI: https://dx.doi.org/10.18565/epidem.2020.10.4.63-5
Vorobyeva O.V., Lastochkin A.V., Gimaldinova N.E., Romanova L.P., Yusov A.A.
1) I.N. Ulyanov Chuvash State University, Cheboksary, Russia; 2) Republican Bureau of Forensic Medicine, Cheboksary, Russia
1. Воробьева О.В., Ласточкин А.В. Клинико-морфологический случай COVID-19. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(2): 90–3. DOI: https://dx.doi.org/10.18565/epidem.2020.2.90-93 Vorobeva O.V., Lastochkin A.V. [A clinical and morphological case of СOVID-19]. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2020; 10(2): 90–3. (In Russ.). DOI: https://dx.doi.org/10.18565/epidem.2020.2.90-93 2. Воробьева О.В., Ласточкин А.В. Патоморфологические изменения в органах при COVID-19. Инфекция и иммунитет 2020; 10(3): 587–90. https://doi.org/10.15789/2220-7619-PCI-1483 Vorobeva O.V., Lastochkin A.V. [Organ-specific pathomorphological changes during COVID-19]. Infektsiya i immunitet 2020; 10(3): 587–90. (In Russ.). https://doi.org/10.15789/2220-7619-PCI-1483 3. Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. DOI: 10.1101/2020.02.03.931766 4. Fan Z., Chen L., Li J., Cheng X., Yang J., Tian C. et al. Clinical features of COVID-19 related liver damage. Clin. Gastroenterol. Hepatol. 2020; 18(7): 1561–6. doi: 10.1016/j.cgh.2020.04.002 5. Hamming I., Timens W., Bulthuis M., Lely A.T., Navis G.J., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203: 631–7. 6. Li L., Li S., Xu M., Yu P., Zheng S., Dua Z. et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv 2020. doi: https://doi.org/10.1101/2020.02.28.20028514. 7. Moon A.J. et al. High mortality rate for SARS-CoV2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J. Hepatol. (advance online publication), 22 May 2020. https://doi.org/10.1016/j.jhep.2020.05.013 8. Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. Liver Int. 2020; 40(6): 1278–81. https://doi.org/10.1111/liv.14470
Olga V. Vorobyeva, Cand. Med. Sci., Associate Professor, Department of General and Clinical Morphology and Forensic Medicine, I.N. Ulyanov Chuvash State University, Cheboksary, Russia; e-mail: olavorobeva@ mail.ru; ORCID: https://orcid. org/0000-0003-3259-3691
Aleksey V. Lastochkin, Senior Lecturer, Department of General and Clinical Morphology and Forensic Medicine, I.N. Ulyanov Chuvash State University; Highest-Category Pathologist, Republican Forensic Medical Examination Office, Ministry of Health of Chuvashia, Cheboksary, Russia; e-mail: alllex.08@mail.ru; ORCID: https://orcid.org/0000-0001-5681-0246
Natalia E. Gimaldinova, Cand. Med. Sci., Associate Professor, Department of General and Clinical Morphology and Forensic Medicine, I.N. Ulyanov Chuvash State Medical University, Cheboksary, Russia; e-mail: rufer06@rambler.ru; ORCID: https://orcid.org/ 0000-0003-2475-3392
Lyubov P. Romanova, Associate Professor, Department of Dermatovenereology with Course of Hygiene, I.N. Ulyanov Chuvash State University, Cheboksary, Russia; e-mail: samung2008@ yandex.ru; ORCID: https://orcid.org/0000-0003-2475-0987
Aleksandr A. Yusov, Associate Professor, Department of Normal and Pathological Physiology, I.N. Ulyanov Chuvash State University, Cheboksary, Russia; e-mail: Yusov1961@ yandexl.ru; ORCID: https://orcid.org/ 0000-0001-6079-1535